Send feedback

STAT2 p.Gln371Glu

c.1111C>G · rs142439434 · VCV731985

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 3 submitters
AlphaMissense
likely benign
0.0842 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.0028%, nfe)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection

Computational evidence

Protein change
AlphaMissense0.0842likely benign
REVEL0.223benign-leaning
SaProtLLR -4.73tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 4.9GERP 0.44, phastCons 1
Regional constrainto/e 0.73unconstrained · MANE · 13 kb · p 6.2e-18 · regional, not allelic
Overall
CADD18.46PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0028% European (non-Finnish) · 33/1,177,604 alleles
Filtering AF 0.002% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00176%
Overall 0.0123% 198/1,606,586 alleles · very rare exomes 174/1,454,582 · genomes 24/152,004 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.485% 206
Remaining individualsnot grpmax-eligible 0.0354% 2,826
European (non-Finnish)grpmax 0.0028% 35,685
Admixed American 0.00173% 57,848

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
STAT2
Protein
p.Gln371Glu
Coding
c.1111C>G
MANE Select
NM_005419
dbSNP
rs142439434
Type
single nucleotide variant
Location
chr12:56350416 (GRCh38)
Gene constraint
LOEUF 0.497 · pLI 0.81 (gnomAD)
Structure
AlphaFold pLDDT 78.45 · 6 PDB
Residue 371
the 'mediates interaction with usp18' region; the 'interaction with heartland virus nss' region; the 'interaction with sftsv virus nss' region; a β-strand
Full STAT2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection (Orphanet):

Inheritance
Autosomal recessive
Onset
Infancy

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/stat2-p-gln371glu (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown